Share Twitter LinkedIn Facebook Email In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. David H. Ilson examines which is the most optimum perioperative treatment in esophageal cancer.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read